FRESENIUS MEDICAL CARE AG (FME.DE) Stock Fundamental Analysis

FRA:FME • DE0005785802

40.95 EUR
-0.04 (-0.1%)
Last: Feb 13, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to FME. FME was compared to 28 industry peers in the Health Care Providers & Services industry. Both the profitability and the financial health of FME get a neutral evaluation. Nothing too spectacular is happening here. FME has a correct valuation and a medium growth rate. FME also has an excellent dividend rating. These ratings would make FME suitable for dividend investing!


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • In the past year FME was profitable.
  • FME had a positive operating cash flow in the past year.
  • FME had positive earnings in each of the past 5 years.
  • Each year in the past 5 years FME had a positive operating cash flow.
FME.DE Yearly Net Income VS EBIT VS OCF VS FCFFME.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 2.33%, FME is in line with its industry, outperforming 44.83% of the companies in the same industry.
  • FME's Return On Equity of 5.55% is in line compared to the rest of the industry. FME outperforms 41.38% of its industry peers.
  • The Return On Invested Capital of FME (3.95%) is comparable to the rest of the industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for FME is below the industry average of 6.14%.
  • The last Return On Invested Capital (3.95%) for FME is above the 3 year average (3.14%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.33%
ROE 5.55%
ROIC 3.95%
ROA(3y)1.65%
ROA(5y)2.29%
ROE(3y)4.06%
ROE(5y)6.04%
ROIC(3y)3.14%
ROIC(5y)4%
FME.DE Yearly ROA, ROE, ROICFME.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

  • With a decent Profit Margin value of 3.66%, FME is doing good in the industry, outperforming 68.97% of the companies in the same industry.
  • FME's Profit Margin has declined in the last couple of years.
  • FME has a Operating Margin of 7.19%. This is in the better half of the industry: FME outperforms 62.07% of its industry peers.
  • In the last couple of years the Operating Margin of FME has declined.
  • FME has a Gross Margin (25.00%) which is in line with its industry peers.
  • In the last couple of years the Gross Margin of FME has declined.
Industry RankSector Rank
OM 7.19%
PM (TTM) 3.66%
GM 25%
OM growth 3Y-13.44%
OM growth 5Y-12.95%
PM growth 3Y-20.33%
PM growth 5Y-16.53%
GM growth 3Y-3.16%
GM growth 5Y-4.44%
FME.DE Yearly Profit, Operating, Gross MarginsFME.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so FME is destroying value.
  • The number of shares outstanding for FME remains at a similar level compared to 1 year ago.
  • Compared to 5 years ago, FME has less shares outstanding
  • Compared to 1 year ago, FME has an improved debt to assets ratio.
FME.DE Yearly Shares OutstandingFME.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
FME.DE Yearly Total Debt VS Total AssetsFME.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

  • FME has an Altman-Z score of 2.21. This is not the best score and indicates that FME is in the grey zone with still only limited risk for bankruptcy at the moment.
  • FME has a better Altman-Z score (2.21) than 62.07% of its industry peers.
  • The Debt to FCF ratio of FME is 5.97, which is a neutral value as it means it would take FME, 5.97 years of fcf income to pay off all of its debts.
  • With a decent Debt to FCF ratio value of 5.97, FME is doing good in the industry, outperforming 75.86% of the companies in the same industry.
  • FME has a Debt/Equity ratio of 0.73. This is a neutral value indicating FME is somewhat dependend on debt financing.
  • With a decent Debt to Equity ratio value of 0.73, FME is doing good in the industry, outperforming 65.52% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.73
Debt/FCF 5.97
Altman-Z 2.21
ROIC/WACC0.68
WACC5.8%
FME.DE Yearly LT Debt VS Equity VS FCFFME.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B

2.3 Liquidity

  • A Current Ratio of 1.36 indicates that FME should not have too much problems paying its short term obligations.
  • The Current ratio of FME (1.36) is better than 65.52% of its industry peers.
  • FME has a Quick Ratio of 1.36. This is a bad value and indicates that FME is not financially healthy enough and could expect problems in meeting its short term obligations.
  • FME has a better Quick ratio (1.00) than 62.07% of its industry peers.
Industry RankSector Rank
Current Ratio 1.36
Quick Ratio 1
FME.DE Yearly Current Assets VS Current LiabilitesFME.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an nice 16.77% over the past year.
  • FME shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -6.43% yearly.
  • FME shows a small growth in Revenue. In the last year, the Revenue has grown by 2.10%.
  • The Revenue has been growing slightly by 2.04% on average over the past years.
EPS 1Y (TTM)16.77%
EPS 3Y-1.97%
EPS 5Y-6.43%
EPS Q2Q%34.15%
Revenue 1Y (TTM)2.1%
Revenue growth 3Y3.15%
Revenue growth 5Y2.04%
Sales Q2Q%2.63%

3.2 Future

  • The Earnings Per Share is expected to grow by 12.20% on average over the next years. This is quite good.
  • FME is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.15% yearly.
EPS Next Y21.73%
EPS Next 2Y12.96%
EPS Next 3Y13.16%
EPS Next 5Y12.2%
Revenue Next Year1.57%
Revenue Next 2Y2.26%
Revenue Next 3Y2.91%
Revenue Next 5Y3.15%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
FME.DE Yearly Revenue VS EstimatesFME.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5B 10B 15B 20B 25B
FME.DE Yearly EPS VS EstimatesFME.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

6

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 10.89 indicates a reasonable valuation of FME.
  • FME's Price/Earnings ratio is rather cheap when compared to the industry. FME is cheaper than 89.66% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of FME to the average of the S&P500 Index (26.68), we can say FME is valued rather cheaply.
  • Based on the Price/Forward Earnings ratio of 9.88, the valuation of FME can be described as reasonable.
  • 86.21% of the companies in the same industry are more expensive than FME, based on the Price/Forward Earnings ratio.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 28.06, FME is valued rather cheaply.
Industry RankSector Rank
PE 10.89
Fwd PE 9.88
FME.DE Price Earnings VS Forward Price EarningsFME.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • FME's Enterprise Value to EBITDA ratio is in line with the industry average.
  • FME's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 13.69
EV/EBITDA 10.63
FME.DE Per share dataFME.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as FME's earnings are expected to grow with 13.16% in the coming years.
PEG (NY)0.5
PEG (5Y)N/A
EPS Next 2Y12.96%
EPS Next 3Y13.16%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

7

5. Dividend

5.1 Amount

  • FME has a Yearly Dividend Yield of 3.51%. Purely for dividend investing, there may be better candidates out there.
  • FME's Dividend Yield is rather good when compared to the industry average which is at 1.83. FME pays more dividend than 96.55% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.84, FME pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.51%

5.2 History

  • The dividend of FME has a limited annual growth rate of 0.31%.
Dividend Growth(5Y)0.31%
Div Incr Years1
Div Non Decr Years2
FME.DE Yearly Dividends per shareFME.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

  • FME pays out 58.83% of its income as dividend. This is a bit on the high side, but may be sustainable.
  • The dividend of FME is growing, but earnings are growing more, so the dividend growth is sustainable.
DP58.83%
EPS Next 2Y12.96%
EPS Next 3Y13.16%
FME.DE Yearly Income VS Free CF VS DividendFME.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B
FME.DE Dividend Payout.FME.DE Dividend Payout, showing the Payout Ratio.FME.DE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

FRESENIUS MEDICAL CARE AG

FRA:FME (2/13/2026, 7:00:00 PM)

40.95

-0.04 (-0.1%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-04
Earnings (Next)02-24
Inst Owners43.91%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap24.03B
Revenue(TTM)19.64B
Net Income(TTM)718.19M
Analysts65.93
Price Target45.79 (11.82%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.51%
Yearly Dividend1.19
Dividend Growth(5Y)0.31%
DP58.83%
Div Incr Years1
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.52%
Min EPS beat(2)14.16%
Max EPS beat(2)14.89%
EPS beat(4)4
Avg EPS beat(4)17.81%
Min EPS beat(4)14.16%
Max EPS beat(4)27.17%
EPS beat(8)7
Avg EPS beat(8)16.37%
EPS beat(12)10
Avg EPS beat(12)13.79%
EPS beat(16)12
Avg EPS beat(16)10.84%
Revenue beat(2)0
Avg Revenue beat(2)-2.52%
Min Revenue beat(2)-3.33%
Max Revenue beat(2)-1.71%
Revenue beat(4)2
Avg Revenue beat(4)0.94%
Min Revenue beat(4)-3.33%
Max Revenue beat(4)6.05%
Revenue beat(8)3
Avg Revenue beat(8)-0.62%
Revenue beat(12)4
Avg Revenue beat(12)-0.64%
Revenue beat(16)6
Avg Revenue beat(16)-0.51%
PT rev (1m)-3.8%
PT rev (3m)-7.45%
EPS NQ rev (1m)12.25%
EPS NQ rev (3m)11.23%
EPS NY rev (1m)0%
EPS NY rev (3m)2.83%
Revenue NQ rev (1m)0.31%
Revenue NQ rev (3m)0.62%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.37%
Valuation
Industry RankSector Rank
PE 10.89
Fwd PE 9.88
P/S 1.22
P/FCF 13.69
P/OCF 9.57
P/B 1.86
P/tB N/A
EV/EBITDA 10.63
EPS(TTM)3.76
EY9.18%
EPS(NY)4.15
Fwd EY10.13%
FCF(TTM)2.99
FCFY7.3%
OCF(TTM)4.28
OCFY10.45%
SpS33.47
BVpS22.07
TBVpS-3.21
PEG (NY)0.5
PEG (5Y)N/A
Graham Number43.21
Profitability
Industry RankSector Rank
ROA 2.33%
ROE 5.55%
ROCE 5.62%
ROIC 3.95%
ROICexc 4.26%
ROICexgc 11.65%
OM 7.19%
PM (TTM) 3.66%
GM 25%
FCFM 8.93%
ROA(3y)1.65%
ROA(5y)2.29%
ROE(3y)4.06%
ROE(5y)6.04%
ROIC(3y)3.14%
ROIC(5y)4%
ROICexc(3y)3.31%
ROICexc(5y)4.22%
ROICexgc(3y)8.52%
ROICexgc(5y)10.56%
ROCE(3y)4.51%
ROCE(5y)5.77%
ROICexgc growth 3Y-7.67%
ROICexgc growth 5Y-10.05%
ROICexc growth 3Y-10.35%
ROICexc growth 5Y-11.48%
OM growth 3Y-13.44%
OM growth 5Y-12.95%
PM growth 3Y-20.33%
PM growth 5Y-16.53%
GM growth 3Y-3.16%
GM growth 5Y-4.44%
F-Score5
Asset Turnover0.64
Health
Industry RankSector Rank
Debt/Equity 0.73
Debt/FCF 5.97
Debt/EBITDA 3.12
Cap/Depr 47.15%
Cap/Sales 3.85%
Interest Coverage 3.87
Cash Conversion 83.24%
Profit Quality 244.33%
Current Ratio 1.36
Quick Ratio 1
Altman-Z 2.21
F-Score5
WACC5.8%
ROIC/WACC0.68
Cap/Depr(3y)41.32%
Cap/Depr(5y)47.87%
Cap/Sales(3y)3.79%
Cap/Sales(5y)4.49%
Profit Quality(3y)300.36%
Profit Quality(5y)267.36%
High Growth Momentum
Growth
EPS 1Y (TTM)16.77%
EPS 3Y-1.97%
EPS 5Y-6.43%
EPS Q2Q%34.15%
EPS Next Y21.73%
EPS Next 2Y12.96%
EPS Next 3Y13.16%
EPS Next 5Y12.2%
Revenue 1Y (TTM)2.1%
Revenue growth 3Y3.15%
Revenue growth 5Y2.04%
Sales Q2Q%2.63%
Revenue Next Year1.57%
Revenue Next 2Y2.26%
Revenue Next 3Y2.91%
Revenue Next 5Y3.15%
EBIT growth 1Y-3.43%
EBIT growth 3Y-10.72%
EBIT growth 5Y-11.17%
EBIT Next Year96.22%
EBIT Next 3Y29.78%
EBIT Next 5Y18.07%
FCF growth 1Y-5.89%
FCF growth 3Y1.25%
FCF growth 5Y3.45%
OCF growth 1Y0.06%
OCF growth 3Y-1.4%
OCF growth 5Y-1.45%

FRESENIUS MEDICAL CARE AG / FME.DE FAQ

What is the fundamental rating for FME stock?

ChartMill assigns a fundamental rating of 5 / 10 to FME.DE.


What is the valuation status for FME stock?

ChartMill assigns a valuation rating of 6 / 10 to FRESENIUS MEDICAL CARE AG (FME.DE). This can be considered as Fairly Valued.


Can you provide the profitability details for FRESENIUS MEDICAL CARE AG?

FRESENIUS MEDICAL CARE AG (FME.DE) has a profitability rating of 5 / 10.


What is the valuation of FRESENIUS MEDICAL CARE AG based on its PE and PB ratios?

The Price/Earnings (PE) ratio for FRESENIUS MEDICAL CARE AG (FME.DE) is 10.89 and the Price/Book (PB) ratio is 1.86.


How sustainable is the dividend of FRESENIUS MEDICAL CARE AG (FME.DE) stock?

The dividend rating of FRESENIUS MEDICAL CARE AG (FME.DE) is 7 / 10 and the dividend payout ratio is 58.83%.